Agilent Technologies, Inc.:戦略・SWOT・企業財務分析

◆英語タイトル:Agilent Technologies, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA8015672
◆発行会社(調査会社):MarketLine
◆発行日:2017年9月30日
◆ページ数:63
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:産業装置・機械
◆販売価格オプション(消費税別)
Single UserUSD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Agilent Technologies, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Agilent Technologies, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Agilent Technologies, Inc. (Agilent or ‘the company’) is a measurement company engaged in providing bio-analytical and electronic measurement solutions. The company operates in the US, China, Japan, and other countries. It is headquartered in Santa Clara, California and employed approximately 11,800 people as on October 31, 2015.

Scope

- Detailed information on Agilent Technologies, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Agilent Technologies, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Agilent Technologies, Inc. including a breakdown and examination of key business segments
- Intelligence on Agilent Technologies, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Agilent Technologies, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Agilent Technologies, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Agilent Technologies, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Agilent Technologies, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Agilent Technologies, Inc.: Company Overview
Agilent Technologies, Inc.: Overview and Key Facts
Agilent Technologies, Inc.: Overview
Agilent Technologies, Inc.: Key Facts
Agilent Technologies, Inc.: Key Employees
Agilent Technologies, Inc.: Key Employee Biographies
Agilent Technologies, Inc.: Major Products and Services
Agilent Technologies, Inc.: Company History
Agilent Technologies, Inc.: Management Statement
Agilent Technologies, Inc.: Locations and Subsidiaries
Agilent Technologies, Inc.: Key Competitors
Agilent Technologies, Inc.: Company Analysis
Agilent Technologies, Inc.: Business Description
Agilent Technologies, Inc.: SWOT Analysis
Agilent Technologies, Inc.: SWOT Overview
Agilent Technologies, Inc.: Strengths
Agilent Technologies, Inc.: Weaknesses
Agilent Technologies, Inc.: Opportunities
Agilent Technologies, Inc.: Threats
Agilent Technologies, Inc.: Corporate Financial Deals Activity
Agilent Technologies, Inc.: Financial Deals Overview
Agilent Technologies, Inc.: Targets and Partners
Agilent Technologies, Inc.: Top Deals 2013 – 2017YTD*
Agilent Technologies, Inc.: Mergers and Acquisitions
Agilent Technologies, Inc.: Corporate Venturing
Agilent Technologies, Inc.: Partnership
Agilent Technologies, Inc.: Divestments
Agilent Technologies, Inc.: Private Equity and Ownership
Agilent Technologies, Inc.: Recent Developments
Agilent Technologies, Inc.: News and Events Summary
Agilent Technologies, Inc.: Business Expansion
Agilent Technologies, Inc.: Contracts
Agilent Technologies, Inc.: Corporate Governance
Agilent Technologies, Inc.: Financial Performance
Agilent Technologies, Inc.: Market Developments
Agilent Technologies, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Agilent Technologies, Inc.: Key Facts
Table 2: Agilent Technologies, Inc.: Key Employees
Table 3: Agilent Technologies, Inc.: Locations and Subsidiaries
Table 4: Agilent Technologies, Inc.: Key Competitors
Table 5: Agilent Technologies, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Agilent Technologies, Inc.: M&A Activity by Geography (TTM*)
Table 7: Agilent Technologies, Inc.: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 8: Agilent Technologies, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Agilent Technologies, Inc.: Targets and Partners
Table 10: Agilent Technologies, Inc.: Top Deals 2013 - 2017YTD*
Table 11: Agilent Technologies, Inc.: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Agilent Technologies, Inc.: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Agilent Technologies, Inc.: Corporate Venturing Volume and Value Trend (2013 - YTD*2017)
Table 14: Agilent Technologies, Inc.: Corporate Venturing by Geography (2013 - YTD*2017)
Table 15: Agilent Technologies, Inc.: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 16: Agilent Technologies, Inc.: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 17: Agilent Technologies, Inc.: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 18: Agilent Technologies, Inc.: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 19: Agilent Technologies, Inc.: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 20: Agilent Technologies, Inc.: News and Events Summary
Table 21: Agilent Technologies, Inc.: Business Expansion
Table 22: Agilent Technologies, Inc.: Contracts
Table 23: Agilent Technologies, Inc.: Corporate Governance
Table 24: Agilent Technologies, Inc.: Financial Performance
Table 25: Agilent Technologies, Inc.: Market Developments
Table 26: Agilent Technologies, Inc.: Strategy and Operations

★海外企業調査レポート[Agilent Technologies, Inc.:戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • PDS Biotechnology Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary PDS Biotechnology Corp (PDS Biotechnology) is a biopharmaceutical company that develops vaccines and immunotherapies for cancer and infectious disease. The company uses versamune technology that is immunostimulatory nanoparticle vaccine platform used for the development of cancer immunothera …
  • The Siam Cement Public Co Ltd:戦略・SWOT・企業財務分析
    The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report Summary The Siam Cement Public Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Nikkei Inc.:企業の戦略的SWOT分析
    Nikkei Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Dis-Chem Pharmacies Limited (DCP):企業の財務・戦略的SWOT分析
    Dis-Chem Pharmacies Limited (DCP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • SMS Pharmaceuticals Ltd (SMSPHARMA):製薬・医療:M&Aディール及び事業提携情報
    Summary SMS Pharmaceuticals Ltd (SMS Pharma) is a manufacturer of active pharmaceutical ingredients (APIs) and intermediates that develops offers anti-fungal, anti-ulcer, anti-migraine, anti-hypersensitive, anti-psychotic, anti-viral and other products. Its pipeline products include Ticagrelor, Clop …
  • Indovina Bank Ltd:企業の戦略的SWOT分析
    Indovina Bank Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Pro Petroleum Inc:企業の戦略的SWOT分析
    Pro Petroleum Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Bertelsmann SE & Co. KGaA:企業の戦略・SWOT・財務分析
    Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report Summary Bertelsmann SE & Co. KGaA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • BioVendor – Laboratorni Medicina as-製薬・医療分野:企業M&A・提携分析
    Summary BioVendor - Laboratorni Medicina as (BioVendor) is a developer and manufacturer of immunoassays, recombinant protiens, antibodies and endotoxin-removal products. The company’s products include immunoassays, proteins, antibodies, endotoxin removal products, endotoxin detection products, immun …
  • Genel Energy Plc (GENL):石油・ガス:M&Aディール及び事業提携情報
    Summary Genel Energy Plc (Genel) is an independent upstream oil and gas company. It carries out acquisition, exploration, and production operations. It has interest in Taq Taq and Tawke in the Kurdistan region. The company develops the Miran and Bina Bawi gas fields in Zagros Fold belt in the Kurdis …
  • Garden Fresh Restaurants, LLC:企業の戦略・SWOT・財務分析
    Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report Summary Garden Fresh Restaurants, LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • BIND Therapeutics Inc (BIND)-製薬・医療分野:企業M&A・提携分析
    Summary BIND Therapeutics Inc (BIND Therapeutics) is a nanomedicine platform company that develops and commercializes preclinical candidates for cardiovascular disease, cancer and inflammatory disease. The company’s pipeline products include BIND-014, an Accurin that contains the well-established ch …
  • Oncolytics Biotech Inc (ONC)-製薬・医療分野:企業M&A・提携分析
    Summary Oncolytics Biotech Inc (Oncolytics) is a development stage biopharmaceutical company which focuses on the discovery and development of oncolytic viruses for the treatment of cancer. The company’s lead product, Reolysin, a formulation of the human reovirus, is at Phase II clinical trials indi …
  • Oversea-Chinese Banking Corp Ltd:企業の戦略・SWOT・財務情報
    Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary Oversea-Chinese Banking Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • GQ Life Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary GQ Life Sciences Inc (GQ Life Sciences), formerly GenomeQuest Inc, a subsidiary of Aptean Inc, is a life science information and search company that offers genomic software to search patents for biological sequences. The company provides lifequest, a patent search tool that provides a soluti …
  • Le Chateau Inc. (CTU):企業の財務・戦略的SWOT分析
    Le Chateau Inc. (CTU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Orexo AB (ORX):製薬・医療:M&Aディール及び事業提携情報
    Summary Orexo AB (Orexo) is a specialty pharmaceutical company that focuses on the research, formulation, development, registration and commercialization of drugs. The company's commercial product portfolio consists of Abstral, Edluar and Zubsolv. its pipeline candidates comprise OX51 for procedure- …
  • Steel Dynamics Inc:戦略・SWOT・企業財務分析
    Steel Dynamics Inc - Strategy, SWOT and Corporate Finance Report Summary Steel Dynamics Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Adamis Pharmaceuticals Corporation:企業のM&A・事業提携・投資動向
    Adamis Pharmaceuticals Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Adamis Pharmaceuticals Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • BESIX Group SA:企業の戦略的SWOT分析
    BESIX Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆